Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $96.8200 (-4.08%) ($96.4000 - $96.8200) on Fri. Mar. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.62% (three month average) | RSI | 30 | Latest Price | $96.8200(-4.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -8.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWO(62%) IBB(61%) IWM(60%) IWN(57%) IWC(56%) | Factors Impacting LGND price | LGND will decline at least -1.81% in a week (0% probabilities). VIXM(-27%) UUP(-20%) VXX(-17%) EDOC(-9%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.81% (StdDev 3.62%) | Hourly BBV | -2.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $82.67(-14.61%) | Resistance Level | $109.95 | 5 Day Moving Average | $99.83(-3.02%) | 10 Day Moving Average | $100.05(-3.23%) | 20 Day Moving Average | $109.95(-11.94%) | To recent high | -40.6% | To recent low | 1.5% | Market Cap | $1.556b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |